LUNG vs FHTX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 17, 2026

LUNG

29.3
AI Score
VS
FHTX Wins

FHTX

32.6
AI Score

Investment Advisor Scores

LUNG

29score
Recommendation
SELL

FHTX

33score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric LUNG FHTX Winner
Revenue 43.34M 19.34M LUNG
Net Income -23.73M -27.07M LUNG
Net Margin -54.8% -140.0% LUNG
Operating Income -22.01M -30.38M LUNG
ROE -60.6% 33.4% FHTX
ROA -20.7% -13.3% FHTX
Total Assets 114.73M 203.39M FHTX
Cash 55.84M 68.08M FHTX
Current Ratio 4.32 3.36 LUNG
Free Cash Flow -15.32M -43.16M LUNG

Relative Price Performance (Last 90 Days)

LUNG 1M: +85.2% · 3M: +46.8% FHTX 1M: +39.4% · 3M: +70.0%

Current Technical Phase

LUNG

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (14.1% over 20 days), RSI 64

RSI (14): 63.6 · Price: $2.26

FHTX

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (16.9% over 20 days), RSI 72

RSI (14): 72.0 · Price: $7.07

Fundamentals Snapshot

Metric LUNG FHTX
Market Cap
Forward P/E -2.4 -6.9
Trailing P/E
Revenue (TTM)
Revenue Growth 0.0% 1.1%
Gross Margin 0.8% -1.1%
Operating Margin -0.4% -0.5%
EPS -1.15 -0.98
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, FHTX is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.